These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
188 related items for PubMed ID: 21094356
21. Effectiveness of implantable cardioverter-defibrillators in patients with ischemic heart disease and left ventricular dysfunction. Chan PS, Chow T, Kereiakes D, Schloss EJ, Waller T, Eagle K, Hayward RA, Vijan S. Arch Intern Med; 2006 Nov 13; 166(20):2228-33. PubMed ID: 17101941 [Abstract] [Full Text] [Related]
22. Predictive significance for sudden death of microvolt-level T wave alternans in New York Heart Association class II congestive heart failure patients: a prospective study. Baravelli M, Salerno-Uriarte D, Guzzetti D, Rossi MC, Zoli L, Forzani T, Salerno-Uriarte JA. Int J Cardiol; 2005 Oct 20; 105(1):53-7. PubMed ID: 16207545 [Abstract] [Full Text] [Related]
23. Long-term survival of patients with heart failure and ventricular conduction delay treated with cardiac resynchronization therapy. Auricchio A, Metra M, Gasparini M, Lamp B, Klersy C, Curnis A, Fantoni C, Gronda E, Vogt J, Multicenter Longitudinal Observational Study (MILOS) Group. Am J Cardiol; 2007 Jan 15; 99(2):232-8. PubMed ID: 17223424 [Abstract] [Full Text] [Related]
24. [Biventricular stimulation therapy in patients with heart failure and tachycardic arrhythmias. Indications--results--prospects]. Trappe HJ. Biomed Tech (Berl); 2002 Oct 15; 47(9-10):243-9. PubMed ID: 12369212 [Abstract] [Full Text] [Related]
25. Clinical predictors and prognostic significance of electrical storm in patients with implantable cardioverter defibrillators. Brigadeau F, Kouakam C, Klug D, Marquié C, Duhamel A, Mizon-Gérard F, Lacroix D, Kacet S. Eur Heart J; 2006 Mar 15; 27(6):700-7. PubMed ID: 16421175 [Abstract] [Full Text] [Related]
26. Role of the implantable defibrillator among elderly patients with a history of life-threatening ventricular arrhythmias. Healey JS, Hallstrom AP, Kuck KH, Nair G, Schron EP, Roberts RS, Morillo CA, Connolly SJ. Eur Heart J; 2007 Jul 15; 28(14):1746-9. PubMed ID: 17283003 [Abstract] [Full Text] [Related]
28. Factors influencing appropriate firing of the implanted defibrillator for ventricular tachycardia/fibrillation: findings from the Multicenter Automatic Defibrillator Implantation Trial II (MADIT-II). Singh JP, Hall WJ, McNitt S, Wang H, Daubert JP, Zareba W, Ruskin JN, Moss AJ, MADIT-II Investigators. J Am Coll Cardiol; 2005 Nov 01; 46(9):1712-20. PubMed ID: 16256874 [Abstract] [Full Text] [Related]
29. Infarct tissue heterogeneity assessed with contrast-enhanced MRI predicts spontaneous ventricular arrhythmia in patients with ischemic cardiomyopathy and implantable cardioverter-defibrillator. Roes SD, Borleffs CJ, van der Geest RJ, Westenberg JJ, Marsan NA, Kaandorp TA, Reiber JH, Zeppenfeld K, Lamb HJ, de Roos A, Schalij MJ, Bax JJ. Circ Cardiovasc Imaging; 2009 May 01; 2(3):183-90. PubMed ID: 19808591 [Abstract] [Full Text] [Related]
30. Myocardial scar characteristics based on cardiac magnetic resonance imaging is associated with ventricular tachyarrhythmia in patients with ischemic cardiomyopathy. Demirel F, Adiyaman A, Timmer JR, Dambrink JH, Kok M, Boeve WJ, Elvan A. Int J Cardiol; 2014 Dec 15; 177(2):392-9. PubMed ID: 25440471 [Abstract] [Full Text] [Related]
31. Prophylactic use of an implantable cardioverter-defibrillator after acute myocardial infarction. Hohnloser SH, Kuck KH, Dorian P, Roberts RS, Hampton JR, Hatala R, Fain E, Gent M, Connolly SJ, DINAMIT Investigators. N Engl J Med; 2004 Dec 09; 351(24):2481-8. PubMed ID: 15590950 [Abstract] [Full Text] [Related]
32. Prevalence and prognostic impact of comorbidities in heart failure patients with implantable cardioverter defibrillator. Bruch C, Bruch C, Sindermann J, Breithardt G, Gradaus R. Europace; 2007 Aug 09; 9(8):681-6. PubMed ID: 17507354 [Abstract] [Full Text] [Related]
33. Predictors of VT/VF-occurrence in ICD patients: results from the PROFIT-Study. Klein G, Lissel C, Fuchs AC, Gardiwal A, Oswald H, Desousa M, Pichlmaier AM, Lichtinghagen R, Geerlings H, Lippolt P, Niehaus M, Drexler H, Korte T. Europace; 2006 Aug 09; 8(8):618-24. PubMed ID: 16864615 [Abstract] [Full Text] [Related]
34. Primary prevention of sudden cardiac death by implantable cardioverter-defibrillator therapy in Chinese patients with heart failure: a single-center experience. Chen TB, Cheng KA, Gao P, Cheng ZW, Fan JB, Jiang XC, Fang Q. Chin Med J (Engl); 2010 Apr 05; 123(7):848-51. PubMed ID: 20497676 [Abstract] [Full Text] [Related]
35. Mortality rates and clinical predictors of reduced survival after cardioverter defibrillator implantation. Thibodeau JB, Pillarisetti J, Khumri TM, Jones PG, Main ML. Am J Cardiol; 2008 Mar 15; 101(6):861-4. PubMed ID: 18328854 [Abstract] [Full Text] [Related]
36. The ABCD (Alternans Before Cardioverter Defibrillator) Trial: strategies using T-wave alternans to improve efficiency of sudden cardiac death prevention. Costantini O, Hohnloser SH, Kirk MM, Lerman BB, Baker JH, Sethuraman B, Dettmer MM, Rosenbaum DS, ABCD Trial Investigators. J Am Coll Cardiol; 2009 Feb 10; 53(6):471-9. PubMed ID: 19195603 [Abstract] [Full Text] [Related]